Uncommon Fatty Acids and Cardiometabolic Health
Abstract
:1. Introduction
2. Furan Fatty Acids and Cardiometabolic Health
2.1. Origin of Furan Fatty Acids
2.2. Evidence from Human Studies
2.3. Evidence from Animal and In Vitro Studies
2.4. Brief Summary
3. DPA and Cardiometabolic Health
3.1. Origin of DPA
3.2. Evidence from Human Studies
3.3. Evidence from Animal and In Vitro Studies
3.4. Brief Summary
4. Conjugated Fatty Acids and Cardiometabolic Health
4.1. Origin of Conjugated Fatty Acids
4.2. CLA and Cardiometabolic Health
4.2.1. Evidence from Human Studies
4.2.2. Evidence from Animal and in Vitro Studies
4.2.3. Brief Summary
4.3. CLNA and Cardiometabolic Health
4.3.1. Evidence from Human Studies
4.3.2. Evidence from Animal and in Vitro Studies
4.3.3. Brief Summary
5. Conclusions and Perspectives
Author Contributions
Funding
Conflicts of Interest
References
- Lloyd-Jones, D.; Adams, R.; Carnethon, M.; De Simone, G.; Ferguson, T.B.; Flegal, K.; Ford, E.; Furie, K.; Go, A.; Greenlund, K.; et al. Heart disease and stroke statistics—2009 update: A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2009, 119, 480–486. [Google Scholar] [PubMed]
- Nelson, R.H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care 2013, 40, 195–211. [Google Scholar] [CrossRef] [PubMed]
- Laakso, M.; Kuusisto, J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 2014, 10, 293–302. [Google Scholar] [CrossRef] [PubMed]
- Cai, H.; Harrison, D.G. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000, 87, 840–844. [Google Scholar] [CrossRef] [PubMed]
- Golia, E.; Limongelli, G.; Natale, F.; Fimiani, F.; Maddaloni, V.; Pariggiano, I.; Bianchi, R.; Crisci, M.; D’Acierno, L.; Giordano, R.; et al. Inflammation and cardiovascular disease: From pathogenesis to therapeutic target. Curr. Atheroscler. Rep. 2014, 16, 435. [Google Scholar] [CrossRef] [PubMed]
- Zalesin, K.C.; Franklin, B.A.; Miller, W.M.; Peterson, E.D.; McCullough, P.A. Impact of obesity on cardiovascular disease. Endocrinol. Metab. Clin. N. Am. 2008, 37, 663–684. [Google Scholar] [CrossRef] [PubMed]
- Wald, D.S.; Law, M.; Morris, J.K. Homocysteine and cardiovascular disease: Evidence on causality from a meta-analysis. BMJ 2002, 325, 1202. [Google Scholar] [CrossRef] [PubMed]
- Potvin, L.; Richard, L.; Edwards, A.C. Knowledge of cardiovascular disease risk factors among the Canadian population: Relationships with indicators of socioeconomic status. CMAJ 2000, 162, S5–S11. [Google Scholar] [PubMed]
- Abdelhamid, A.S.; Brown, T.J.; Brainard, J.S.; Biswas, P.; Thorpe, G.C.; Moore, H.J.; Deane, K.H.; AlAbdulghafoor, F.K.; Summerbell, C.D.; Worthington, H.V.; et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 2018, 7, Cd003177. [Google Scholar] [CrossRef] [PubMed]
- Alhassan, A.; Young, J.; Lean, M.E.J.; Lara, J. Consumption of fish and vascular risk factors: A systematic review and meta-analysis of intervention studies. Atherosclerosis 2017, 266, 87–94. [Google Scholar] [CrossRef] [PubMed]
- Chowdhury, R.; Stevens, S.; Gorman, D.; Pan, A.; Warnakula, S.; Chowdhury, S.; Ward, H.; Johnson, L.; Crowe, F.; Hu, F.B.; et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: Systematic review and meta-analysis. BMJ 2012, 345, e6698. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Clarke, R.; Daly, L.; Robinson, K.; Naughten, E.; Cahalane, S.; Fowler, B.; Graham, I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 1991, 324, 1149–1155. [Google Scholar] [CrossRef] [PubMed]
- Huang, T.; Zheng, J.; Chen, Y.; Yang, B.; Wahlqvist, M.L.; Li, D. High consumption of omega-3 polyunsaturated fatty acids decrease plasma homocysteine: A meta-analysis of randomized, placebo-controlled trials. Nutrition 2011, 27, 863–867. [Google Scholar] [CrossRef] [PubMed]
- Li, K.; Huang, T.; Zheng, J.; Wu, K.; Li, D. Effect of marine-derived n-3 polyunsaturated fatty acids on c-reactive protein, interleukin 6 and tumor necrosis factor alpha: A meta-analysis. PLoS ONE 2014, 9, e88103. [Google Scholar]
- Maki, K.C.; Palacios, O.M.; Bell, M.; Toth, P.P. Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gaps. J. Clin. Lipidol. 2017, 11, 1152–1160. [Google Scholar] [CrossRef] [PubMed]
- Fleming, J.A.; Kris-Etherton, P.M. The evidence for alpha-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv. Nutr. 2014, 5, 863s–876s. [Google Scholar] [CrossRef] [PubMed]
- Pan, A.; Chen, M.; Chowdhury, R.; Wu, J.H.; Sun, Q.; Campos, H.; Mozaffarian, D.; Hu, F.B. Alpha-linolenic acid and risk of cardiovascular disease: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2012, 96, 1262–1273. [Google Scholar] [CrossRef] [PubMed]
- Farvid, M.S.; Ding, M.; Pan, A.; Sun, Q.; Chiuve, S.E.; Steffen, L.M.; Willett, W.C.; Hu, F.B. Dietary linoleic acid and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Circulation 2014, 130, 1568–1578. [Google Scholar] [CrossRef] [PubMed]
- Huth, P.J.; Fulgoni, V.L.; Larson, B.T. A systematic review of high-oleic vegetable oil substitutions for other fats and oils on cardiovascular disease risk factors: Implications for novel high-oleic soybean oils. Adv. Nutr. 2015, 6, 674–693. [Google Scholar] [CrossRef] [PubMed]
- Xu, L.; Sinclair, A.J.; Faiza, M.; Li, D.; Han, X.; Yin, H.; Wang, Y. Furan fatty acids—Beneficial or harmful to health? Prog. Lipid. Res. 2017, 68, 119–137. [Google Scholar] [CrossRef] [PubMed]
- Gunstone, F.D.; Chakra Wijesundera, R.; Scrimgeour, C.M. The component acids of lipids from marine and freshwater species with special reference to furan-containing acids. J. Sci. Food Agric. 1978, 29, 539–550. [Google Scholar] [CrossRef]
- Hannemann, K.; Puchta, V.; Simon, E.; Ziegler, H.; Ziegler, G.; Spiteller, G. The common occurrence of furan fatty acids in plants. Lipids 1989, 24, 296–298. [Google Scholar] [CrossRef] [PubMed]
- Batna, A.; Scheinkönig, J.; Spiteller, G. The occurrence of furan fatty acids in isochrysis sp. and phaeodactylum tricornutum. Biochim. Biophys. Acta 1993, 1166, 171–176. [Google Scholar] [CrossRef]
- Kazlauskas, R.; Murphy, P.; Wells, R.; Gregson, R. Two new furans from the brown alga acrocarpia paniculata: The use of 4-phenyl-4h-1,2,4-triazoline-3,5-dione to determine the substitution pattern of a furan. Aust. J. Chem. 1982, 35, 165–170. [Google Scholar] [CrossRef]
- Ishii, K.; Okajima, H.; Koyamatsu, T.; Okada, Y.; Watanabe, H. The composition of furan fatty acids in the crayfish. Lipids 1988, 23, 694–700. [Google Scholar] [CrossRef] [PubMed]
- Dembitsky, V.M.; Rezanka, T. Furan fatty acids of some brackish invertebrates from the caspian sea. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 1996, 114, 317–320. [Google Scholar] [CrossRef]
- Schödel, R.; Spiteller, G. Über das vorkommen von F-säuren in Rinderleber und deren enzymatischen Abbau bei Gewebeverletzung. Liebigs Annalen der Chemie 1987, 1987, 459–462. [Google Scholar] [CrossRef]
- Wahl, H.G.N.; Chrzanowski, A.; Mu¨ller, C.; Liebich, H.M.; Hoffmann, A. Identification of furan fatty acids in human blood cells and plasma by multi-dimensional gas chromatography-mass spectrometry. J. Chromatogr. A 1995, 697, 453–459. [Google Scholar] [CrossRef]
- Vetter, W.; Laure, S.; Wendlinger, C.; Mattes, A.; Smith, A.W.T.; Knight, D.W. Determination of furan fatty acids in food samples. J. Am. Oil Chem. Soc. 2012, 89, 1501–1508. [Google Scholar] [CrossRef]
- Vysotskii, M.V.; Ota, T.; Takagi, T. N-3 polyunsaturated fatty acids in lipids of ascidian halocynthia roretzi. Nippon Suisan Gakkaishi 1992, 58, 953–958. [Google Scholar] [CrossRef]
- Norifumi, S.; Kiyohiko, N.; Sakayu, S. Occurrence of a furan fatty acid in marine bacteria. Biochim. Biophys. Acta 1995, 1258, 225–227. [Google Scholar] [CrossRef]
- Wakimoto, T.; Kondo, H.; Nii, H.; Kimura, K.; Egami, Y.; Oka, Y.; Yoshida, M.; Kida, E.; Ye, Y.; Akahoshi, S.; et al. Furan fatty acid as an anti-inflammatory component from the green-lipped mussel perna canaliculus. Proc. Natl. Acad. Sci. USA 2011, 108, 17533–17537. [Google Scholar] [CrossRef] [PubMed]
- Angioni, A.; Addis, P. Characterization of the lipid fraction of wild sea urchin from the Sardinian sea (Western Mediterranean). J. Food Sci. 2014, 79, C155–C162. [Google Scholar] [CrossRef] [PubMed]
- Spiteller, G. Furan fatty acids: Occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet? Lipids 2005, 40, 755–771. [Google Scholar] [CrossRef] [PubMed]
- Glass, R.L.; Krick, T.P.; Sand, D.M.; Rahn, C.H.; Schlenk, H. Furanoid fatty acids from fish lipids. Lipids 1975, 10, 695–702. [Google Scholar] [CrossRef] [PubMed]
- Wahl, H.G.; Tetschner, B.; Liebich, H.M. The effect of dietary fish oil supplementation on the concentration of 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid in human blood and urine. J. High. Resolut. Chromatogr. 1992, 15, 815–818. [Google Scholar] [CrossRef]
- Zheng, J.S.; Lin, M.; Imamura, F.; Cai, W.; Wang, L.; Feng, J.P.; Ruan, Y.; Tang, J.; Wang, F.; Yang, H.; et al. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: A double-blind randomised controlled trial. Sci. Rep. 2016, 6, 29522. [Google Scholar] [CrossRef] [PubMed]
- Tovar, J.; De Mello, V.D.; Nilsson, A.; Johansson, M.; Paananen, J.; Lehtonen, M.; Hanhineva, K.; Bjorck, I. Reduction in cardiometabolic risk factors by a multifunctional diet is mediated via several branches of metabolism as evidenced by nontargeted metabolite profiling approach. Mol. Nutr. Food Res. 2017, 61. [Google Scholar] [CrossRef] [PubMed]
- Fu, Y.; Li, G.; Zhang, X.; Xing, G.; Hu, X.; Yang, L.; Li, D. Lipid extract from hard-shelled mussel (Mytilus coruscus) improves clinical conditions of patients with rheumatoid arthritis: A randomized controlled trial. Nutrients 2015, 7, 625–645. [Google Scholar] [CrossRef] [PubMed]
- Rahn, C.H.; Sand, D.M.; Wedmid, Y.; Schlenk, H.; Krick, T.P.; Glass, R.L. Synthesis of naturally occurring furan fatty acids. J. Org. Chem. 1979, 44, 3420–3424. [Google Scholar] [CrossRef]
- Prentice, K.J.; Wendell, S.G.; Liu, Y.; Eversley, J.A.; Salvatore, S.R.; Mohan, H.; Brandt, S.L.; Adams, A.C.; Serena Wang, X.; Wei, D.; et al. CMPF, a metabolite formed upon prescription omega-3-acid ethyl ester supplementation, prevents and reverses steatosis. EBioMedicine 2018, 27, 200–213. [Google Scholar] [CrossRef] [PubMed]
- Prentice, K.J.; Luu, L.; Allister, E.M.; Liu, Y.; Jun, L.S.; Sloop, K.W.; Hardy, A.B.; Wei, L.; Jia, W.; Fantus, I.G.; et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces beta cell dysfunction. Cell Metab. 2014, 19, 653–666. [Google Scholar] [CrossRef] [PubMed]
- Sand, D.M.; Schlenk, H.; Thoma, H.; Spiteller, G. Catabolism of fish furan fatty acids to urofuran acids in the rat. Biochim. Biophys. Acta 1983, 751, 455–461. [Google Scholar] [CrossRef]
- Okada, Y.; Okajima, H.; Konishi, H.; Terauchi, M.; Ishii, K.; Liu, I.-M.; Watanabe, H. Antioxidant effect of naturally occurring furan fatty acids on oxidation of linoleic acid in aqueous dispersion. J. Am. Oil Chem. Soc. 1990, 67, 858–862. [Google Scholar] [CrossRef]
- Okada, Y.; Kaneko, M.; Okajima, H. Hydroxyl radical scavenging activity of naturally occurring furan fatty acids. Biol. Pharm. Bull. 1996, 19, 1607–1610. [Google Scholar] [CrossRef] [PubMed]
- McIntyre, T.M.; Hazen, S.L. Lipid oxidation and cardiovascular disease: Introduction to a review series. Circ. Res. 2010, 107, 1167–1169. [Google Scholar] [CrossRef] [PubMed]
- Kaur, G.; Guo, X.F.; Sinclair, A.J. Short update on docosapentaenoic acid: A bioactive long-chain n-3 fatty acid. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 88–91. [Google Scholar] [CrossRef] [PubMed]
- Kabeya, N.; Takeuchi, Y.; Yamamoto, Y.; Yazawa, R.; Haga, Y.; Satoh, S.; Yoshizaki, G. Modification of the n-3 HUFA biosynthetic pathway by transgenesis in a marine teleost, nibe croaker. J. Biotechnol. 2014, 172, 46–54. [Google Scholar] [CrossRef] [PubMed]
- Yang, B.; Ren, X.L.; Huang, H.; Guo, X.J.; Ma, A.G.; Li, D. Circulating long-chain n-3 polyunsaturated fatty acid and incidence of stroke: A meta-analysis of prospective cohort studies. Oncotarget 2017, 8, 83781–83791. [Google Scholar] [CrossRef] [PubMed]
- Chowdhury, R.; Warnakula, S.; Kunutsor, S.; Crowe, F.; Ward, H.A.; Johnson, L.; Franco, O.H.; Butterworth, A.S.; Forouhi, N.G.; Thompson, S.G.; et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis. Ann. Intern. Med. 2014, 160, 398–406. [Google Scholar] [CrossRef] [PubMed]
- Mozaffarian, D.; Lemaitre, R.N.; King, I.B.; Song, X.; Huang, H.; Sacks, F.M.; Rimm, E.B.; Wang, M.; Siscovick, D.S. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: A cohort study. Ann. Intern. Med. 2013, 158, 515–525. [Google Scholar] [CrossRef] [PubMed]
- Friedman, A.N.; Yu, Z.; Denski, C.; Tamez, H.; Wenger, J.; Thadhani, R.; Li, Y.; Watkins, B. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis. Am. J. Nephrol. 2013, 38, 12–18. [Google Scholar] [CrossRef] [PubMed]
- Leng, G.C.; Horrobin, D.F.; Fowkes, F.G.; Smith, F.B.; Lowe, G.D.; Donnan, P.T.; Ells, K. Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case-control study. Arterioscler. Thromb. 1994, 14, 471–478. [Google Scholar] [CrossRef] [PubMed]
- Hino, A.; Adachi, H.; Toyomasu, K.; Yoshida, N.; Enomoto, M.; Hiratsuka, A.; Hirai, Y.; Satoh, A.; Imaizumi, T. Very long chain n-3 fatty acids intake and carotid atherosclerosis: An epidemiological study evaluated by ultrasonography. Atherosclerosis 2004, 176, 145–149. [Google Scholar] [CrossRef] [PubMed]
- Linderborg, K.M.; Kaur, G.; Miller, E.; Meikle, P.J.; Larsen, A.E.; Weir, J.M.; Nuora, A.; Barlow, C.K.; Kallio, H.P.; Cameron-Smith, D.; et al. Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88, 313–319. [Google Scholar] [CrossRef] [PubMed]
- Maki, K.C.; Bobotas, G.; Dicklin, M.R.; Huebner, M.; Keane, W.F. Effects of mat9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables. J. Clin. Lipidol. 2017, 11, 102–109. [Google Scholar] [CrossRef] [PubMed]
- Dai Perrard, X.Y.; Lian, Z.; Bobotas, G.; Dicklin, M.R.; Maki, K.C.; Wu, H. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia. J. Clin. Lipidol. 2017, 11, 1361–1371. [Google Scholar] [CrossRef] [PubMed]
- Markworth, J.F.; Kaur, G.; Miller, E.G.; Larsen, A.E.; Sinclair, A.J.; Maddipati, K.R.; Cameron-Smith, D. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid. FASEB J. 2016, 30, 3714–3725. [Google Scholar] [CrossRef] [PubMed]
- Norris, J.M.; Kroehl, M.; Fingerlin, T.E.; Frederiksen, B.N.; Seifert, J.; Wong, R.; Clare-Salzler, M.; Rewers, M. Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: The diabetes autoimmunity study in the young. Diabetologia 2014, 57, 295–304. [Google Scholar] [CrossRef] [PubMed]
- Li, D.; Turner, A.; Sinclair, A.J. Relationship between platelet phospholipid FA and mean platelet volume in healthy men. Lipids 2002, 37, 901–906. [Google Scholar] [CrossRef] [PubMed]
- Morin, C.; Blier, P.U.; Fortin, S. Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model. Arthritis Res. Ther. 2015, 17, 142. [Google Scholar] [CrossRef] [PubMed]
- Vik, A.; Dalli, J.; Hansen, T.V. Recent advances in the chemistry and biology of anti-inflammatory and specialized pro-resolving mediators biosynthesized from n-3 docosapentaenoic acid. Bioorg. Med. Chem. Lett. 2017, 27, 2259–2266. [Google Scholar] [CrossRef] [PubMed]
- Guo, X.F.; Sinclair, A.J.; Kaur, G.; Li, D. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice. Prostaglandins Leukot. Essent. Fatty Acids 2017. [Google Scholar] [CrossRef] [PubMed]
- Huang, J.P.; Cheng, M.L.; Hung, C.Y.; Wang, C.H.; Hsieh, P.S.; Shiao, M.S.; Chen, J.K.; Li, D.E.; Hung, L.M. Docosapentaenoic acid and docosahexaenoic acid are positively associated with insulin sensitivity in rats fed high-fat and high-fructose diets. J. Diabetes 2017, 9, 936–946. [Google Scholar] [CrossRef] [PubMed]
- Kaur, G.; Sinclair, A.J.; Cameron-Smith, D.; Barr, D.P.; Molero-Navajas, J.C.; Konstantopoulos, N. Docosapentaenoic acid (22:5n-3) down-regulates the expression of genes involved in fat synthesis in liver cells. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85, 155–161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Phang, M.; Garg, M.L.; Sinclair, A.J. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-redefining platelet response to fish oils. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81, 35–40. [Google Scholar] [CrossRef] [PubMed]
- Yuan, G.; Chen, X.; Li, D. Modulation of peroxisome proliferator-activated receptor gamma (PPAR gamma) by conjugated fatty acid in obesity and inflammatory bowel disease. J. Agric. Food Chem. 2015, 63, 1883–1895. [Google Scholar] [CrossRef] [PubMed]
- Kepler, C.R.; Hirons, K.P.; McNeill, J.J.; Tove, S.B. Intermediates and products of the biohydrogenation of linoleic acid by butyrinvibrio fibrisolvens. J. Biol. Chem. 1966, 241, 1350–1354. [Google Scholar] [PubMed]
- Chin, S.F.; Liu, W.; Storkson, J.M.; Ha, Y.L.; Pariza, M.W. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compost. Anal. 1992, 5, 185–197. [Google Scholar] [CrossRef]
- Özgül-Yücel, S. Determination of conjugated linolenic acid content of selected oil seeds grown in Turkey. J. Am. Oil Chem. Soc. 2005, 82, 893–897. [Google Scholar] [CrossRef]
- Takagi, T.; Itabashi, Y. Occurrence of mixtures of geometrical isomers of conjugated octadecatrienoic acids in some seed oils: Analysis by open-tubular gas liquid chromatography and high performance liquid chromatography. Lipids 1981, 16, 546–551. [Google Scholar] [CrossRef]
- Chisholm, M.J.; Hopkins, C.Y. Isolation and structure of a new conjugated triene fatty acid 1. J. Org. Chem. 1962, 27, 3137–3139. [Google Scholar] [CrossRef]
- Kijima, R.; Honma, T.; Ito, J.; Yamasaki, M.; Ikezaki, A.; Motonaga, C.; Nishiyama, K.; Tsuduki, T. Jacaric acid is rapidly metabolized to conjugated linoleic acid in rats. J. Oleo Sci. 2013, 62, 305–312. [Google Scholar] [CrossRef] [PubMed]
- Yuan, G.; Sinclair, A.J.; Xu, C.; Li, D. Incorporation and metabolism of punicic acid in healthy young humans. Mol. Nutr. Food Res. 2009, 53, 1336–1342. [Google Scholar] [CrossRef] [PubMed]
- Smit, L.A.; Baylin, A.; Campos, H. Conjugated linoleic acid in adipose tissue and risk of myocardial infarction. Am. J. Clin. Nutr. 2010, 92, 34–40. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sluijs, I.; Plantinga, Y.; De Roos, B.; Mennen, L.I.; Bots, M.L. Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am. J. Clin. Nutr. 2010, 91, 175–183. [Google Scholar] [CrossRef] [PubMed]
- Raff, M.; Tholstrup, T.; Basu, S.; Nonboe, P.; Sorensen, M.T.; Straarup, E.M. A diet rich in conjugated linoleic acid and butter increases lipid peroxidation but does not affect atherosclerotic, inflammatory, or diabetic risk markers in healthy young men. J. Nutr. 2008, 138, 509–514. [Google Scholar] [CrossRef] [PubMed]
- Eftekhari, M.; Aliasghari, F.; Beigi, M.A.; Hasanzadeh, J. The effect of conjugated linoleic acids and omega-3 fatty acids supplementation on lipid profile in atherosclerosis. Adv. Biomed. Res. 2014, 3, 15. [Google Scholar] [PubMed]
- Riserus, U.; Vessby, B.; Arnlov, J.; Basu, S. Effects of cis-9,trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am. J. Clin. Nutr. 2004, 80, 279–283. [Google Scholar] [CrossRef] [PubMed]
- Riserus, U.; Basu, S.; Jovinge, S.; Fredrikson, G.N.; Arnlov, J.; Vessby, B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated c-reactive protein: A potential link to fatty acid-induced insulin resistance. Circulation 2002, 106, 1925–1929. [Google Scholar] [CrossRef] [PubMed]
- Hassan Eftekhari, M.; Aliasghari, F.; Babaei-Beigi, M.A.; Hasanzadeh, J. Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients. ARYA Atheroscler. 2013, 9, 311–318. [Google Scholar] [PubMed]
- Lee, K.N.; Kritchevsky, D.; Pariza, M.W. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis 1994, 108, 19–25. [Google Scholar] [CrossRef]
- Kritchevsky, D.; Tepper, S.A.; Wright, S.; Czarnecki, S.K.; Wilson, T.A.; Nicolosi, R.J. Conjugated linoleic acid isomer effects in atherosclerosis: Growth and regression of lesions. Lipids 2004, 39, 611–616. [Google Scholar] [CrossRef] [PubMed]
- Kritchevsky, D.; Tepper, S.A.; Wright, S.; Tso, P.; Czarnecki, S.K. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J. Am. Coll. Nutr. 2000, 19, 472S–477S. [Google Scholar] [CrossRef] [PubMed]
- Kritchevsky, D.; Tepper, S.A.; Wright, S.; Czarnecki, S.K. Influence of graded levels of conjugated linoleic acid (CLA) on experimental atherosclerosis in rabbits. Nutr. Res. 2002, 22, 1275–1279. [Google Scholar] [CrossRef]
- Toomey, S.; Harhen, B.; Roche, H.M.; Fitzgerald, D.; Belton, O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis 2006, 187, 40–49. [Google Scholar] [CrossRef] [PubMed]
- De Gaetano, M.; Dempsey, E.; Marcone, S.; James, W.G.; Belton, O. Conjugated linoleic acid targets beta2 integrin expression to suppress monocyte adhesion. J. Immunol. 2013, 191, 4326–4336. [Google Scholar] [CrossRef] [PubMed]
- Dipasquale, D.; Basirico, L.; Morera, P.; Primi, R.; Troscher, A.; Bernabucci, U. Anti-inflammatory effects of conjugated linoleic acid isomers and essential fatty acids in bovine mammary epithelial cells. Animal 2018, 12, 2108–2114. [Google Scholar] [CrossRef] [PubMed]
- Bassaganya-Riera, J.; Reynolds, K.; Martino-Catt, S.; Cui, Y.; Hennighausen, L.; Gonzalez, F.; Rohrer, J.; Benninghoff, A.U.; Hontecillas, R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004, 127, 777–791. [Google Scholar] [CrossRef] [PubMed]
- Whigham, L.D.; Cook, E.B.; Stahl, J.L.; Saban, R.; Bjorling, D.E.; Pariza, M.W.; Cook, M.E. CLA reduces antigen-induced histamine and PGE2 release from sensitized guinea pig tracheae. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280, R908–R912. [Google Scholar] [CrossRef] [PubMed]
- Whigham, L.D.; Higbee, A.; Bjorling, D.E.; Park, Y.; Pariza, M.W.; Cook, M.E. Decreased antigen-induced eicosanoid release in conjugated linoleic acid-fed guinea pigs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 282, R1104–R1112. [Google Scholar] [CrossRef] [PubMed]
- Aloud, B.M.; Raj, P.; O’Hara, K.; Shao, Z.; Yu, L.; Anderson, H.D.; Netticadan, T. Conjugated linoleic acid prevents high glucose-induced hypertrophy and contractile dysfunction in adult rat cardiomyocytes. Nutr. Res. 2016, 36, 134–142. [Google Scholar] [CrossRef] [PubMed]
- Bezan, P.N.; Holland, H.; De Castro, G.S.; Cardoso, J.F.R.; Ovidio, P.P.; Calder, P.C.; Jordao, A.A. High dose of a conjugated linoleic acid mixture increases insulin resistance in rats fed either a low fat or a high fat diet. Exp. Clin. Endocrinol. Diabetes 2018, 126, 379–386. [Google Scholar] [CrossRef] [PubMed]
- Mirmiran, P.; Fazeli, M.R.; Asghari, G.; Shafiee, A.; Azizi, F. Effect of pomegranate seed oil on hyperlipidaemic subjects: A double-blind placebo-controlled clinical trial. Br. J. Nutr. 2010, 104, 402–406. [Google Scholar] [CrossRef] [PubMed]
- Dhar, P.; Bhattacharyya, D.; Bhattacharyya, D.K.; Ghosh, S. Dietary comparison of conjugated linolenic acid (9 cis, 11 trans, 13 trans) and alpha-tocopherol effects on blood lipids and lipid peroxidation in alloxan-induced diabetes mellitus in rats. Lipids 2006, 41, 49–54. [Google Scholar] [CrossRef] [PubMed]
- Manterys, A.; Franczyk-Zarow, M.; Czyzynska-Cichon, I.; Drahun, A.; Kus, E.; Szymczyk, B.; Kostogrys, R.B. Haematological parameters, serum lipid profile, liver function and fatty acid profile of broiler chickens fed on diets supplemented with pomegranate seed oil and linseed oil. Br. Poult. Sci. 2016, 57, 771–779. [Google Scholar] [CrossRef] [PubMed]
- Arao, K.; Yotsumoto, H.; Han, S.Y.; Nagao, K.; Yanagita, T. The 9 cis, 11 trans, 13 cis isomer of conjugated linolenic acid reduces apolipoprotein b100 secretion and triacylglycerol synthesis in hepg2 cells. Biosci. Biotechnol. Biochem. 2004, 68, 2643–2645. [Google Scholar] [CrossRef] [PubMed]
- Noguchi, R.; Yasui, Y.; Suzuki, R.; Hosokawa, M.; Fukunaga, K.; Miyashita, K. Dietary effects of bitter gourd oil on blood and liver lipids of rats. Arch. Biochem. Biophys. 2001, 396, 207–212. [Google Scholar] [CrossRef] [PubMed]
- Saha, S.S.; Patra, M.; Ghosh, M. In vitro antioxidant study of vegetable oils containing conjugated linolenic acid isomers. LWT-Food Sci. Technol. 2012, 46, 10–15. [Google Scholar] [CrossRef]
- Saha, S.S.; Ghosh, M. Comparative study of antioxidant activity of α-eleostearic acid and punicic acid against oxidative stress generated by sodium arsenite. Food Chem. Toxicol. 2009, 47, 2551–2556. [Google Scholar] [CrossRef] [PubMed]
- Mukherjee, C.; Bhattacharyya, S.; Ghosh, S.; Bhattacharyya, D.K. Dietary effects of punicic acid on the composition and peroxidation of rat plasma lipid. J. Oleo Sci. 2002, 51, 513–522. [Google Scholar] [CrossRef]
- Boussetta, T.; Raad, H.; Letteron, P.; Gougerot-Pocidalo, M.A.; Marie, J.C.; Driss, F.; El-Benna, J. Punicic acid a conjugated linolenic acid inhibits tnfalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS ONE 2009, 4, e6458. [Google Scholar] [CrossRef] [PubMed]
- Lewis, S.N.; Brannan, L.; Guri, A.J.; Lu, P.; Hontecillas, R.; Bassaganya-Riera, J.; Bevan, D.R. Dietary alpha-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-gamma. PLoS ONE 2011, 6, e24031. [Google Scholar] [CrossRef] [PubMed]
- Saha, S.S.; Ghosh, M. Antioxidant and anti-inflammatory effect of conjugated linolenic acid isomers against streptozotocin-induced diabetes. Br. J. Nutr. 2012, 108, 974–983. [Google Scholar] [CrossRef] [PubMed]
- Mashhadi, Z.; Boeglin, W.E.; Brash, A.R. Robust inhibitory effects of conjugated linolenic acids on a cyclooxygenase-related linoleate 10s-dioxygenase: Comparison with cox-1 and cox-2. Biochim. Biophys. Acta 2015, 1851, 1346–1352. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Li, K.; Sinclair, A.J.; Zhao, F.; Li, D. Uncommon Fatty Acids and Cardiometabolic Health. Nutrients 2018, 10, 1559. https://doi.org/10.3390/nu10101559
Li K, Sinclair AJ, Zhao F, Li D. Uncommon Fatty Acids and Cardiometabolic Health. Nutrients. 2018; 10(10):1559. https://doi.org/10.3390/nu10101559
Chicago/Turabian StyleLi, Kelei, Andrew J. Sinclair, Feng Zhao, and Duo Li. 2018. "Uncommon Fatty Acids and Cardiometabolic Health" Nutrients 10, no. 10: 1559. https://doi.org/10.3390/nu10101559